Coping with ignorance: Exploring pharmacologic management for pediatric functional abdominal pain

Journal of Pediatric Gastroenterology and Nutrition

Volumn 41, Issue 5, 2005, Pages 569-574

  Campo, John V ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; ANTIDEPRESSANT AGENT; BULKING AGENT; CALCIUM CHANNEL; CITALOPRAM; CYPROHEPTADINE; DESIPRAMINE; FAMOTIDINE; FLUOXETINE; HISTAMINE H2 RECEPTOR ANTAGONIST; PAROXETINE; PEPPERMINT OIL; PIZOTIFEN; PROPRANOLOL; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SPASMOLYTIC AGENT; TEGASEROD;

ABDOMINAL PAIN; APPETITE DISORDER; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COPING BEHAVIOR; DIETARY FIBER; DIZZINESS; DROWSINESS; HISTAMINE RELEASE; HUMAN; IRRITABLE COLON; META ANALYSIS; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SMOOTH MUSCLE RELAXATION; SYSTEMATIC REVIEW;

ABDOMINAL PAIN; CHILD; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; DIETARY FIBER; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HUMANS; PSYCHOTROPIC DRUGS;

MENTHA X PIPERITA;

EID: 27644578232     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000189326.65076.65     Document Type: Review

References (67)

1. Apley J, Naish N. Recurrent abdominal pains: a field study of 1,000 school children. Arch Dis Child 1958;33:165-70.
2. Di Lorenzo C, Colletti R, Lehmann H, et al. Chronic abdominal pain in children: a technical report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, [review]. J Pediatr Gastroenterol Nutr 2005;40:249-61.
3. Scharff L. Recurrent abdominal pain in children: a review of psychological factors and treatment. Clin Psychol Rev 1997;17:145-66.
4. Starfield B, Gross E, Wood M, et al. Psychosocial and psychosomatic diagnoses in primary care of children. Pediatr 1980;66:159-67.
5. Drossman DA, Corazziari E, Talley NJ, et al. Rome II: The Functional Gastrointestinal Disorders-Diagnosis, pathophysiology and treatment: A multinational consensus, 2nd ed. McLean, VA: Degnon Associates; 2000.
6. Rasquin-Weber A, Hyman PE, Cucchiara S, et al. Childhood functional gastrointestinal disorders. Gut 1999;45:1160-8.
7. Walker LS, Lipani TA, Greene JW, et al. Recurrent Abdominal pain: Symptom Subtypes based on the Rome II criteria for pediatric functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr 2004;38:187-91.
8. Huertas-Ceballos A, Macarthur C, Logan S. Dietary interventions for recurrent abdominal pain (RAP) in childhood. Cochrane Database Syst Rev 2002(2):CDO03019.
9. Huertas-Ceballos A, Macarthur C, Logan S. Pharmacological interventions for recurrent abdominal pain (RAP) in childhood. Cochrane Database Syst Rev 2002(1):CDO03017.
10. Edwards MC, Mullins LL, Johnson J, et al. Survey of pediatricians' management practices for recurrent abdominal pain. J Pediatr Psychol 1994;19:241-53.
11. Campo J, Comer D, Jansen-McWilliams L, et al. Recurrent pain, emotional distress, and health service use in childhood. J Pediatr 2002;141:76-83.
12. Stickler G, Murphy D. Recurrent abdominal pain. Am J Dis Child 1979;133:486-9.
13. Walker L, Garber J, Greene J. Psychosocial correlates of recurrent childhood pain: a comparison of pediatric patients with recurrent abdominal pain, organic illness, and psychiatric disorders. J Abnorm Psychol 1993;102:248-5.
14. Campo JV, Bridge J, Ehmann M, et al. Recurrent abdominal pain, anxiety, and depression in primary care. Pediatr 2004;113:817-24.
15. Garber J, Zeman J, Walker L. Recurrent abdominal pain in children: Psychiatric diagnoses and parental psychopathology. J Am Acad Child Adolesc Psychiatry & Adolescent Psychiatry 1990;29:648-56.
16. Hyams J, Burke G, Davis P, et al. Abdominal pain and irritable bowel syndrome in adolescents: A community-based study. J Pediatr 1996;129:220-6.
17. Liakopoulou-Kairis M, Alifieraki T, Protagora D, et al. Recurrent abdominal pain and headache: Psychopathology, life event and family functioning. Eur Child Adolesc Psychiatry 2002;11:115-22.
18. Bernstein G, Shaw K. Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry 1997;36(10 Suppl):69S-84.
19. Birmaher B, Ryan N, Williamson D, et al. Childhood and adolescent depression: a review of the past 10 years. Part I. [comment]. J Am Acad Child Adolesc Psychiatry 1996;35:1427-39.
20. Sanders MR, Rebgetz M, Morrison M, et al. Cognitive-behavioral treatment of recurrent nonspecific abdominal pain in children: an analysis of generalization, maintenance, and side effects. J Consult Clin Psychol 1989;57:294-300.
21. Sanders MR, Shepherd RW, Cleghorn G, et al. The treatment of recurrent abdominal pain in children: a controlled comparison of cognitive-behavioral family intervention and standard pediatric care. J Consult Clin Psychol 1994;62:306-14.
22. Finney JW, Iemanek KI, Cataldo MF, et al. Pediatric psychology in primary healthcare: Brief targeted therapy for recurrent abdominal pain. Behav Ther 1989;20:283-91.
23. Sank LI, Biglan A. Operant treatment of a case of a recurrent abdominal pain in a ten year old boy. Behav Ther 1974;5:677-81.
24. Miller AJ, Kratochwill RT. Reduction of frequent stomachache complaints by time out. Behav Ther 1979;10:211-8.
25. Ball TM, Shapiro DE, Monheim CJ, et al. A pilot study of the use of guided imagery for the treatment of recurrent abdominal pain in children. Clin Pediatr 2003;42:527-32.
26. Anbar RD. Self-hypnosis for the treatment of functional abdominal pain in childhood. Clin Pediatr 2001;40:447-51.
27. Hyams JS, Hyman PE. Recurrent abdominal pain and the biopsychosocial model of medical practice. [comment]. J Pediatr 1998;133:473-8.
28. Lebenthal E, Rossi T, Nord K, et al. Recurrent abdominal pain and lactose absorption in children. Pediatr 1981;67:828-32.
29. Christensen M. Recurrent abdominal pain and dietary fiber. Am J Dis Child 1986;140:738-9.
30. Feldman W, McGrath P, Hodgson C, et al. The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double-blind, randomized, controlled trial. Am J Dis Child 1985;139:1216-8.
31. Humphreys P, Gervirtz R. Treatment of recurrent abdominal pain: component analysis of four treatment protocols. J Pediatr Gastroenterol Nutr 2000;31:47-51.
32. Jailwala J, Imperiale T, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials. Ann Intern Med 2000;133:136-47.
33. Kline RM, Kline JJ, Di Palma J, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr 2001;138:125-8.
34. See MC, Birnbaum AH, Schechter CB, et al. Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment. Dig Dis & Sciences 2001;46:985-92.
35. Symon O, Russell G. A double-blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Arch Dis Child 1995;72:48-50.
36. Worawattanakul M, Rhoads JM, Lichtman SN, et al. Abdominal migraine: prophylactic treatment and follow-up. J Pediatr Gastroenterol Nutr 1999;28:37-40.
37. Gershon M. Review article: Roles played by 5-hydroxytryptamine in the physiology of the bowel. Aliment Pharmacol Ther 1999;13(Suppl 2):15-30.
38. Tabas G, Beaves M, Wang J, et al. Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, Placebo-controlled trial. [see comment]. Am J Gastroenterol 2004;99:914-20.
39. Campo JV, Perel J, Lucas A, et al. Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: An exploratory study. J Am Acad Child Adolesc Psychiatry 2004;43(10):1234-42.
40. Bezchlibnyk-Butler K, Aleksic I, Kennedy SH. Citalopram-a review of pharmacological and clinical effects. J Psychiatry Neurosci 2000;25:241-54.
41. Brosen K, Naranjo CA. Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram. Eur Neuropsychopharmacol 2001;11:275-83.
42. Preskorn S. Outpatient management of depression: A guide for the primary-care practitioner: Professional Communications, Inc.; 1999.
43. Birmaher B, Axelson DA, Monk K, et al. Fluoxetine for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 2003;42:415-23.
44. Walkup J, Labellart M, Riddle M, et al. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001;344:1279-85.
45. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebocontrolled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54:1031-7.
46. Wagner KD, Robb A, Findling R, et al. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. [see comment]. Am J Psychiatry 2004;161:1079-1083.
47. Jackson JL, O'Malley PG, Tomkins G, et al. Treatment of functional gastrointestinal disorders with antidepressant medications: of meta-analysis. Am J Med 2000;108:65-72.
48. Drossman DA, Toner BB, Whitehead WE, et al. Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. [comment]. Gastroenterology 2003;125:19-31.
49. Geller B, Reising D, Leonard HL, et al. Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry 1999;38:513-6.
50. Di Lorenzo C, Youssef N, Sigurdsson L, et al. Visceral hyperalgesia in children with functional abdominal pain. J Pediatr 2001;139:838-43.
51. Ginkel R, Voskuljl W, Benninga M, et al. Alterations in rectal sensitivity and motility in childhood irritable bowel syndrome. Gastroenterology 2001;120:31-8.
52. Alfven G. The pressure pain threshold (PPT) of certain muscles in children suffering from recurrent abdominal pain of non-organic origin. An Algometric Study. Acta Pediatricia 1993;82:481-3.
53. Duarte M, Goulart E, Penna F. Pressure pain threshold in children with recurrent abdominal pain. J Pediatr Gastroenterol Nutr 2000;31:280-5.
54. Kim D. Serotonin; A mediator of the brain-gun connection. Am J Gastroenterol 2000;95:2698-709.
55. Camilleri M. Serotonergic modulation of visceral sensation: Lower gut. Gut 2002;51(Suppl 1):i81-6.
56. Wood J, Alpers D, Andrews G. Fundamentals of neurogastroenterology. Gut 1999;45(Suppl 2):116-1116.
57. Wang Q, Nakai Y. The dorsal raphe: An important nucleus in pain modulation. Brain Res Bull 1994;34:575-8.
58. Bueno L, Fioramonti J, Delvaux M, et al. Mediators and pharmacology of visceral sensitivity: From basic to clinical investigations. Gastroenterology 1997;112:1714-43.
59. Charney D, Deutsch A. A functional neuroanatomy of anxiety and fear: Implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol 1996;10:419-46.
60. Camilleri M, Atanasova E, Carlson P, et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 2002;123:425-32.
61. Hariri AR, Mattay VS, Tessitore A, et al. Serotonin transporter genetic variation and the response of the human amygdala. [comment]. Science 2002;297:400-3.
62. Greenberg B, Li Q, Lucas F, et al. Association between the serotonin transporter promoter polymorphism and personality traitsin a primarily female sample. Am J Med Genet 2000;96:202-16.
63. Lesen K, Bengel D, Heils A, et al. Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1483.
64. LeDoux JE. The Emotional Brain. New York: Simon and Schuster; 1996.
65. Campo J, Fritz G. A management model for pediatric somatization. Psychosomatics 2001;42:467-76.
66. Walker L, Sorrells S. Brief report: Assessment of children's gastrointestinal symptoms for clinical trials. J Pediatr Psychol 2002;27:303-7.
67. van Zanten SJOV, Talley NJ, Bytzer P, et al. Design of treatment trials for functional gastrointestinal disorders. Gut 1999;45(Suppl 11):1169-77.